IL2RG and renal cell carcinoma: The results depicted in Table 2 shows that subcutaneous injection of 103 RCC-41-PDX-1/CD132+-1.0 cells into SCID mice induced the formation of tumors within 3 weeks in all studied mice (n = 8 mice), while subcutaneous injection of 102 RCC-41-PDX-1/CD132+-1.0 induced the formation of tumors in 2 out of 8 mice.